NSEESOP/ESOS/ESPS10 Jul 2026 · 10 Jul 2026, 07:01 pm

ESOP/ESOS/ESPS

Sai Life Sciences Limited · SAILIFE

✦ AI SummaryESG

Sai Life Sciences Limited has informed the Exchange regarding the allotment of 8,900 shares under the Employees Stock Option Plan 2008 (ESOP 2008).

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sai Life Sciences Limited has informed the Exchange regarding Allotment of 8900 Shares.

Attachments (1)

📄

SAILIFE_10072026190052_Intimation.pdf

pdf

Download →
View document text
10 July 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Street Exchange Plaza, C-1, Block G, Bandra Kurla Mumbai – 400001 Complex, Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544306 NSE Scrip Symbol: SAILIFE Sub: Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Allotment of equity shares under Employees Stock Option Plan 2008 (“ESOP 2008”). Dear Sir/ Madam, Pursuant to Regulation 30 read with Schedule III to the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors of the Company has approved and allotted 8,900 fully paid-up equity shares of Re.1/ each upon exercise of options granted under ESOP 2008 vide circular resolution dated 10 July 2026. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed herewith as Annexure-A. Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024 are enclosed as Annexure-B. We request you to take note of the same and oblige. Thank you. For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No.: A13721 Encl: As above Sai Life Sciences Limited (CIN: U24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Annexure - A Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. 1 Company name and address of Registered Office: Sai Life Sciences Limited Plot No. DS-7, IKP Knowledge Park, Turkapally (V) Shameerpet Mandal, Medchal- Malkajgiri Dist, Rangareddi, Hyderabad, Telangana, India, 500078 2 Name of the Stock Exchanges on which the company’s shares are listed: BSE Limited (“BSE”) National Stock Exchange of India Limited (“NSE”) 3 Filing date of the statement referred in regulation 10(b) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with Stock Exchange: 08 January 2025 (BSE & NSE) 4 Filing Number, if any: ESOP 2008 BSE 220872 NSE 46558 5 Title of the Scheme pursuant to which shares are issued, if any: Employees Stock Option Plan 2008 6 Kind of security to be listed: Equity Shares 7 Par value of the shares: Rs. 1/- per share 8 Date of issue of shares: 10 July 2026 (Allotment on exercise of options) 9 Number of shares issued: 8,900 10 Share Certificate No., if applicable: Not Applicable. Shares are issued in Dematerialized form 11 Distinctive number of the share, if applicable: 21,22,86,017 to 21,22,94,916 (both inclusive) 12 ISIN Number of the shares if issued in Demat: INE570L01029 Sai Life Sciences Limited (CIN: U24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. 13 Exercise price per share: Rs. 188.90/- per share per allotment of 8,900 shares (ESOP 2008) 14 Premium per share: Rs. 187.90/- per share (ESOP 2008) 15 Total Issued shares after this issue: 21,22,94,916 16 Total Issued share capital after this issue: 21,22,94,916 17 Details of any lock-in on the shares: NA 18 Date of expiry of lock-in: NA 19 Whether shares identical in all respects to existing shares if not, when will they become identical: NA 20 Details of listing fees, if payable: NA Sai Life Sciences Limited (CIN: U24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Annexure-B Details required under Regulation 30 read with Schedule III of the Listing Regulations and as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024. Sl. Disclosures Particulars a) brief details of options The present instance is for allotment of shares upon granted exercise of 8,900 options under ESOP 2008. b) Whether the scheme is in Yes terms of SEBI (SBEB) Regulations, 2021 (if applicable) c) total number of shares covered The present disclosure is in respect of allotment of by these options 8,900 shares made on 10 July 2026. d) pricing formula The price payable by an Employee on Exercise is determined by the Nomination and Remuneration Committee and in conformity with applicable accounting Standards, the SEBI SBEB & SE Regulations as applicable from time to time. e) options vested NA as the intimation is towards allotment of shares pursuant to exercise of ESOPs f) time within which option may NA as the intimation is towards allotment of shares be exercised pursuant to exercise of ESOPs g) options exercised The present instance is for allotment of shares upon exercise of 8,900 options under ESOP 2008. h) money realized by exercise of INR 16,81,210 options i) the total number of shares 8,900 arising as a result of exercise of option j) options lapsed NA as the intimation is towards allotment of shares pursuant to exercise of ESOPs k) variation of terms of options NA l) brief details of significant The objective of ESOP 2008 (“ESOP Plan”) are to terms provide an incentive to attract, retain and reward employees and contribute to the growth of the Company. The ESOP Plan have a maximum vesting period of 5 years with multiple options of vesting as per clause 5 of the ESOP Plan. The exercise period is till the employee is in the service of the company as per clause 7 of ESOP Plan. m) subsequent changes or NA cancellation or exercise of such options n) diluted earnings per share NA pursuant to issue of equity shares on exercise of options Sai Life Sciences Limited (CIN: U24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India.